Top ▲
Unless otherwise stated all data on this page refer to the human proteins. Gene information is provided for human (Hs), mouse (Mm) and rat (Rn).
« Hide
More detailed introduction
Bromodomain (BRD)-containing kinases initiate acetylation-dependent assembly of transcriptional regulator complexes by binding to (or 'reading') acetyl-lysine marks on histone tails. The regulator complexes thus formed, control expression of sets of proteins which alter the cellular phenotype in specific ways. (BRD)-containing proteins are exciting targets for the development of novel small molecule therapeutics in the areas of cancer, inflammation and viral infection [1].
BRD1 (bromodomain containing 1)
Show summary »
More detailed page |
BRD2 (bromodomain containing 2)
Show summary »
More detailed page |
BRD3 (bromodomain containing 3)
Show summary »
More detailed page |
BRD4 (bromodomain containing 4)
Show summary »
More detailed page |
BRD7 (bromodomain containing 7)
Show summary »
More detailed page |
BRD8 (bromodomain containing 8)
Show summary »
More detailed page |
BRD9 (bromodomain containing 9)
Show summary »
More detailed page |
Database page citation:
Bromodomain kinase (BRDK) family. Accessed on 08/06/2023. IUPHAR/BPS Guide to PHARMACOLOGY, http://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=558.
Concise Guide to PHARMACOLOGY citation:
Alexander SP, Fabbro D, Kelly E, Mathie A, Peters JA, Veale EL et al. (2021) THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Enzymes. Br J Pharmacol. 178 Suppl 1:S313-S411.